Ibyerekeye-kanseri / kuvura / ibiyobyabwenge / myeloproliferative-neoplasms

Ibiyobyabwenge Byemewe kuri Myeloproliferative Neoplasms

Uru rupapuro rugaragaza imiti ya kanseri yemejwe n’ubuyobozi bushinzwe ibiryo n’ibiyobyabwenge (FDA) kuri neoplasme ya myeloproliferative. Urutonde rurimo amazina rusange nibiranga. Uru rupapuro kandi rugaragaza urutonde rwibiyobyabwenge bisanzwe bikoreshwa muri myeloproliferative neoplasms. Ibiyobyabwenge kugiti cye hamwe byemewe na FDA. Nyamara, guhuza ibiyobyabwenge ubwabyo mubisanzwe ntabwo byemewe, ariko birakoreshwa cyane.

Amazina yibiyobyabwenge ahuza incamake yamakuru ya Kanseri ya NCI. Hashobora kubaho imiti ikoreshwa muri myeloproliferative neoplasms itanditswe hano.

Ibiyobyabwenge Byemewe kuri Myeloproliferative Neoplasms

Adriamycin PFS (Doxorubicin Hydrochloride)

Adriamycin RDF (Doxorubicin Hydrochloride)

Arsenic Trioxide

Azacitidine

Cerubidine (Daunorubicin Hydrochloride)

Clafen (Cyclophosphamide)

Cyclophosphamide

Cytarabine

Cytosar-U (Cytarabine)

Cytoxan (Cyclophosphamide)

Dacogen (Decitabine)

Dasatinib

Daunorubicin Hydrochloride

Decitabine

Doxorubicin Hydrochloride

Fedratinib Hydrochloride

Gleevec (Imatinib Mesylate)

Imatinib Mesylate

Inrebic (Fedratinib Hydrochloride)

Jakafi (Fosifate ya Ruxolitinib)

Nilotinib

Rubidomycine (Daunorubicin Hydrochloride)

Ruxolitinib Fosifate

Sprycel (Dasatinib)

Tarabine PFS (Cytarabine)

Tasigna (Nilotinib)

Trisenox (Arsenic Trioxide)

Vidaza (Azacitidine)

Ibiyobyabwenge bikoreshwa muri Myeloproliferative Neoplasms

ADE